Accendra Health Inc (NYSE:ACH) — Market Cap & Net Worth
Market Cap & Net Worth: Accendra Health Inc (ACH)
Accendra Health Inc (NYSE:ACH) has a market capitalization of $236.19 Million ($236.19 Million) as of August 1, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #15822 globally and #3721 in its home market, demonstrating a -1.28% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Accendra Health Inc's stock price $3.09 by its total outstanding shares 76437917 (76.44 Million). See ACH capex reinvestment rate to understand how much of operating cash flow is reinvested back into capital assets.
Accendra Health Inc Market Cap History: 2026 to 2026
Accendra Health Inc's market capitalization history from 2026 to 2026. Data shows growth from $236.19 Million to $236.19 Million (0.00% CAGR).
Accendra Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Accendra Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ACH by Market Capitalization
Companies near Accendra Health Inc in the global market cap rankings as of August 1, 2026.
Key companies related to Accendra Health Inc by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #272 globally with a market cap of $94.62 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #525 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #624 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1092 globally with a market cap of $24.01 Billion USD ( AU$33.94 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #272 | McKesson Corporation | NYSE:MCK | $94.62 Billion | $856.19 |
| #525 | Cencora Inc. | NYSE:COR | $50.53 Billion | $311.34 |
| #624 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $230.03 |
| #1092 | Sigma Healthcare Ltd | AU:SIG | $24.01 Billion | AU$2.94 |
Accendra Health Inc Historical Marketcap From 2026 to 2026
Between 2026 and today, Accendra Health Inc's market cap moved from $236.19 Million to $ 236.19 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $236.19 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Accendra Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $236.19 Million USD |
| MoneyControl | $236.19 Million USD |
| MarketWatch | $236.19 Million USD |
| marketcap.company | $236.19 Million USD |
| Reuters | $236.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Accendra Health Inc
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level pos… Read more